Background There are few data on the quantitative effects of cigarette smoking on lung function in young adults. These effects are important in the understanding of the early stages of chronic airflow obstruction. Results The first model showed a significant dose-response relation between the average rate of smoking during the study period and 6FEV,, giving an estimate of annual change in FEV, of -0-42 ml for each cigarette smoked per day (-8-4 ml for each pack) (p = 0 04). In the second model, which took smoking before the study period as a potential confounder, the effect of smoking during the study period was slightly smaller (-0 33 ml/year for each cigarette smoked per day). This indicated that smoking before the study period had a marginal latent effect on 5FEV, during the study. However, neither the effect of smoking before the study nor that of smoking during the study was significant, presumably because of collinearity. Interactions between cigarette smoking and gender, wheezing, atopy, and exposure to environmental tobacco smoke during the growth period were not significant with respect to their effect on the relation between cigarette smoking and 5FEV, Conclusion Cigarette smoking has a dose related adverse effect on the evolution of ventilatory lung function in young adulthood.
Methods A longitudinal study over eight years was carried out to estimate quantitatively the effect of cigarette smoking on ventilatory lung function in young adults and to examine the possibility that the effect is modified by other factors. The study population were 15 to 40 years of age at initial examination, when they underwent spirometry and completed an interviewer administered questionnaire on respiratory health. Eight years later 391 of the subjects were re-examined (38% response rate). The quantitative effect of cigarette smoking during the study period on the average change of forced expiratory volume in one second (FEVy) over time (bFEV1) was estimated in two linear regression models that included potential confounders and other determinants of outcome.
Results
The first model showed a significant dose-response relation between the average rate of smoking during the study period and 6FEV,, giving an estimate of annual change in FEV, of -0-42 ml for each cigarette smoked per day (-8-4 ml for each pack) (p = 0 04). In the second model, which took smoking before the study period as a potential confounder, the effect of smoking during the study period was slightly smaller (-0 33 ml/year for each cigarette smoked per day). This indicated that smoking before the study period had a marginal latent effect on 5FEV, during the study. However, neither the effect of smoking before the study nor that of smoking during the study was significant, presumably because of collinearity. Interactions between cigarette smoking and gender, wheezing, atopy, and exposure to environmental tobacco smoke during the growth period were not significant with respect to their effect on the relation between cigarette smoking and 5FEV, Conclusion Cigarette smoking has a dose related adverse effect on the evolution of ventilatory lung function in young adulthood.
Introduction
Understanding the early evolution of ventilatory impairment is important for the prevention of chronic obstructive pulmonary disease as this disease develops gradually over time and symptoms severe enough to raise concern appear at a late stage of the disease. Cigarette smoking has been identified to be the most important determinant of ventilatory impairment. '25 In longitudinal studies smoking has been shown to impair the growth of forced expiratory volume in one second (FEVy) in children23 and cause an accelerated decline in FEV, in adults.""22 Only In their eight year prospective study of 792 men Fletcher et al found that smoking seemed to affect only a subgroup of smokers, suggesting a susceptibility that could be affected by other environmental hazards. The determinants of susceptibility to the effects of smoking have been difficult to identify. Several other probable determinants of ventilatory function have been recognised, including genetic factors, atopy, non-specific airways hyperresponsiveness, childhood respiratory illness, the presence of respiratory symptoms, socioeconomic status, alcohol consumption, exposure to environmental tobacco smoke, outdoor air pollution, and certain occupational exposures.2627 Their role as potential modifiers of the effects of cigarette smoking on ventilatory function, however, has yet to be studied. In our cross sectional study ofthe effects of smoking on lung function in young adults we found that the adverse effects of smoking were limited to a subgroup of subjects with wheezing, suggesting that wheezing is an important indicator of individual susceptibility. 24 The objectives of the present study were to estimate quantitatively the effect of cigarette smoking during the study period on change in ventilatory function in young adults and to examine whether this effect is modified by other factors.
Methods

STUDY POPULATION
The baseline population consisted of 1044 young, white adults, who were 15 to 40 years of age at initial examination in 1980-1. The population was recruited from a high school, a junior college, and two banking institutions in Montreal. To be included the subject had to perform at least one acceptable spirometric test. More detailed description of the baseline population is given in a previous report.' Follow up surveys were carried out in 1981-2 and 1982-3. A total of 603 subjects (58% of the baseline population) participated in the first follow up survey and 453 subjects (43%) in the second survey.
In 1988-9 all subjects from the baseline study were contacted and asked to participate in a follow up study. To Exposure The exposure to tobacco smoke of the study population was categorised according to the answers to the questionnaires at baseline and in 1988-9 as follows: (i) index category, which included continuous cigarette smoking (cigarette smoker in 1980-1 and in 1988-9) and cigarette smoking started during the study period (never smoker in 1980-1 and cigarette smoker in 1988-9); (ii) reference category, which included no exposure to tobacco smoke (never smoker in 1980-1 and in 1988-9); and (iii) other smoking category, which included all the other forms of exposure to tobacco smoke (cigarette smoker in 1980-1 who gave up smoking during the study period, former cigarette smoker in 1980-1 and in 1988-9, former cigarette smoker in 1980-1 who started smoking again during the study period, never smoker in 1988-9 and former cigarette smoker in 1988-9, current or former smoker of pipe or cigar, or both).
The main determinant of interest was cigarette smoking during the study period (index category). Cigarette smoking was measured quantitatively as the average rate of smoking during the study period (estimated as the average number of cigarettes smoked daily in 1988-9). Cigarette smoking before the study period was considered separately as a potential confounder of the effect of cigarette smoking during the study period on 6FEV1. As The quantitative effect of cigarette smoking on 6FEV, was assessed in a multiple linear regression model, adjustment being made for all potential confounders to obtain an unbiased estimate. 35 The quantitation of cigarette smoking (cigarettes per day) during the study period was included as the main determinant of interest. Cigarette smoking before the study period could have affected 5FEV, during the study directly, or indirectly through a decrease in baseline FEV, which is a determinant of 6FEV,. Adjustment for baseline FEV, would be expected to control for only indirect confounding. As smoking before and during the study period were likely to be correlated inclusion of earlier smoking was problematic and models with and without earlier smoking were fitted.
In the regression analysis the contrast of cigarette smoking during the study period (index category) with never smoking (reference category) was achieved by including an indicator ("dummy") variate of the other smoking category (coding 1 = yes, 0 = no). Outcome in the reference category was thus defined when all the variates of smoking were 0. The variates of smoking and all the covariates were fitted in the main effects model.
Cigarette smoking for the index category was expressed quantitatively with two variates: (1) the mean rate of cigarette smoking during the study period, and (2) the cumulative number of cigarettes smoked before the study period. The main interest was in the prospective study of the effect ofcigarette smoking on 5FEV, during the study period. Two models to explain 3FEV1 were fitted with different variates of quantitative smoking: model 1 with variate 1 only and model 2 with variates 1 and 2 as independent variates.
The question of sensitivity to the effects of smoking was addressed by studying modification in the additive model. The following variates were considered as potential modifiers: gender, wheezing, atopy, and exposure to environmental tobacco smoke during the growth period. The numbers of subjects with asthma (nine) and childhood respiratory illness (six) were too small to study. With all the potential confounders in the model modification of the effect of exposure was studied by introducing exposure-covariate product terms one by one and retaining them in the model according to the significance of the regression coefficient *Four subjects re-examined were excluded from the study population.
tp < 0 05 For the difference between the study population and those lost to follow up ( t test). *Four subjects who were re-examined were excluded from the study population.
tp < 0-05 For the difference between the study population and those lost to follow up ( t test). Tables 1 and 2 give the baseline characteristics of the study population, subjects lost to follow up, and the original baseline population. There were significantly more men in the study population (45%) than among subjects lost to follow up (37%). The study population was significantly older than subjects lost to follow up (p < 0-05) for both men and women, but their baseline FEVy and forced vital capacity did not differ. The study population differed from those not followed up with respect to only two other baseline characteristics: self reported asthma diagnosed by a doctor and wheezing were less common among those re-examined than among those not followed up, the differences being significant only in women. There were no significant differences in the proportion of current cigarette smokers between the two groups. Cigarette years before the studyt: 
Results
COMPARISON OF BASELINE CHARACTERISTICS
SMOKING HABITS DURING FOLLOW UP
In the study population 99 subjects (25%) smoked cigarettes at baseline and throughout the study period, and four subjects (1%) started smoking during the study period (table 3) . Thus the total number of exposed subjects (index category) was 103 (26%)-25 men and 78 women. There were 164 subjects (42%)-82 men and 82 women-who had never smoked (the reference group). The remaining 124 subjects (32%) had different types of current and previous exposures to tobacco products. Table  3 gives the distribution of exposure during (in cigarettes per day) and before the study period (in cigarette years) for the index category.
STRATIFIED ANALYSES
Simple linear regression showed a significant decreasing trend of 5FEV, with age in both men and women who had never smoked (the reference group, p < 0 01) and smokers (the index group, p < 0-05 Table 4 Linear regression models of quantitative effect of cigarette smoking on ( FEV, (ml/year). Main effects models with different exposure variates. tFor each cigarette smoked per day (the average smoking rate during the study period). tFor each cigarette year (calculated by the average number of cigarettes smoked daily as reported in 1980-1 multiplied by the duration of smoking before the study in years).
highly corrrelated (r = 0 80), so collinearity was probably responsible for the lack of significance of the variates when included concurrently in model 2.36 Age, gender, height, and baseline FEV1 were all significant determinants of 6FEV, in both models with different choices ofexposure. None of the other covariates included in the models was significant. The effect ofcigarette smoking on 5FEV1 was not modified significantly by gender, wheezing, atopy or exposure to environmental tobacco smoke during the growth period. Discussion Our first objective was to provide a quantitative estimate of the effect of cigarette smoking on change in ventilatory lung function over time in young adults. Because of the longitudinal study design it was possible to use individual change in FEV1 as the outcome and the average rate of smoking during the eight year study period as an estimate of exposure. Cigarette smoking before the study period, however, is a potential confounder when studying the effect of cigarette smoking on (FEV, during the study period, and the high correlation between smoking before and during the study period made it difficult to differentiate these two effects. Two models were fitted to illustrate the effects of cigarette smoking. The first model showed a significant dose-response relation between smoking during the study period and 6FEV1, giving an estimate ofannual change of -8-4 ml for each pack smoked per day, corresponding to an excess decline of 65 ml during the study period. This estimate is likely to include an effect of earlier smoking on (FEVI. In the second model, which contained smoking before and during the study period, the effect of smoking during the study period was slightly smaller (-6-6 ml/year for each pack smoked per day or -4-3 ml/year per 100 cigarette years). The effect of smoking before the study period was -1-0 ml/year per 100 cigarette years. This is compatible with the hypothesis that smoking before the study period has had a slight continued effect on 3FEV1 during the study period in addition to its effect on initial FEVy. Thus the second model provides for the unconfounded estimate of the effect of smoking during the study period. However, apparently as a result of the high collinearity of smoking before and during the study period neither effect was significant in this model.
Comparison with the estimates from other studies is difficult to make because ofdifferences in age ranges and in definitions of outcome and exposure. The age and FEVI/height3 adjusted estimate of the FEV, slope of Fletcher et al was -0 3 ml/year/1000 packs of lifetime exposure. 25 Peat et al reported recently a longitudinal study of 225 smokers and 759 never smokers from Australia, in which they estimated the association of the number of cigarettes smoked daily at the end of the study with decline of FEVI/height3 during the preceding years."2 The decline of FEV1 after adjusting for age in linear regression was 011 ml/m3/year multiplied by the number of cigarettes smoked daily as reported in the final survey.
When studying the environmental determinants of lung function in young adulthood one of the major issues is how to adjust for the effect of age on the natural evolution of ventilatory lung function. During the age period studied ventilatory function reaches its maximum level and begins a gradual decline with aging. In terms of change in lung function over time we assumed there to be a monotonic decline from a positive to a negative change. A significant linear decreasing relation between 6FEV1 and age was found in both men and women never smokers and smokers. While a linear relation seems to be a good estimate, it is likely that the true relation is sigmoidal, indicating a plateau between the growth and decline phases.3334
Our second objective was to study modification ofthe effect of cigarette smoking on 3FEV1 by other factors, with special reference to wheezing. Wheezing, atopy, exposure to environmental tobacco smoke during the growth period, and gender did not modify this relation significantly. Our cross sectional study of the baseline population suggested that wheezing modifies the effect of smoking on FEV1 significantly. 24 Our finding was consistent with the results of Lebowitz et al in a follow up study of 353 subjects aged 5-5 to 15 years at the time of their initial testing.37 They found that those who smoked and had respiratory symptoms (cough, phlegm, wheeze, attacks of shortness of breath or wheeze, or any asthma) had the lowest end point FEV1 and Vmax50 residuals (observed -predicted). We could not, however, find evidence of modification of the effect of smoking on change in FEV1 by wheezing. Longitudinal study design is usually considered stronger than a cross sectional study design, but a lower power due to a smaller number of observations may have been a limitation in studying modification in our study. It is also possible that wheezing develops concurrently with smoking in susceptible smokers. In this case it would be difficult to show the modification during the study period. The question as to whether wheezing indicates susceptibility to the effect of cigarette smoking on change in ventilatory function needs further research.
The proportion of the initial population that is lost to follow up is an important problem in longitudinal studies. In studies similar to ours the follow up rates have varied between 30% and 75%.1012 
